- Home
- PHAR vs SSYS Comparison
PHAR vs SSYS Comparison
Compare PHAR & SSYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- SSYS
- Stock Information
- Founded
- PHAR 1988
- SSYS 1989
- Country
- PHAR Netherlands
- SSYS United States
- Employees
- PHAR N/A
- SSYS N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- SSYS Computer peripheral equipment
- Sector
- PHAR Health Care
- SSYS Technology
- Exchange
- PHAR Nasdaq
- SSYS Nasdaq
- Market Cap
- PHAR 731.1M
- SSYS 857.2M
- IPO Year
- PHAR N/A
- SSYS 1994
- Fundamental
- Price
- PHAR $10.00
- SSYS $11.18
- Analyst Decision
- PHAR Strong Buy
- SSYS Strong Buy
- Analyst Count
- PHAR 3
- SSYS 4
- Target Price
- PHAR $30.00
- SSYS $12.50
- AVG Volume (30 Days)
- PHAR 3.6K
- SSYS 408.1K
- Earning Date
- PHAR 07-31-2025
- SSYS 08-28-2025
- Dividend Yield
- PHAR N/A
- SSYS N/A
- EPS Growth
- PHAR N/A
- SSYS N/A
- EPS
- PHAR N/A
- SSYS N/A
- Revenue
- PHAR $320,708,000.00
- SSYS $564,454,000.00
- Revenue This Year
- PHAR $13.31
- SSYS $2.01
- Revenue Next Year
- PHAR $7.68
- SSYS $4.01
- P/E Ratio
- PHAR N/A
- SSYS N/A
- Revenue Growth
- PHAR 24.13
- SSYS N/A
- 52 Week Low
- PHAR $6.65
- SSYS $6.05
- 52 Week High
- PHAR $12.61
- SSYS $12.88
- Technical
- Relative Strength Index (RSI)
- PHAR 43.61
- SSYS 53.25
- Support Level
- PHAR $9.99
- SSYS $10.63
- Resistance Level
- PHAR $10.59
- SSYS $11.90
- Average True Range (ATR)
- PHAR 0.35
- SSYS 0.34
- MACD
- PHAR -0.14
- SSYS 0.01
- Stochastic Oscillator
- PHAR 7.45
- SSYS 56.89
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About SSYS Stratasys Ltd. (Israel)
Stratasys Ltd is a polymer-based 3D printing solution, which provides a product life cycle, with multiple technologies and complete solutions for superior application fit, across industrial, healthcare, and consumer fields. It focuses, in particular, on polymer 3D printing solutions that address the fastest-growing manufacturing solutions viewed as the potential growth opportunity in the 3D printing industry. Its printers include FDM, PolyJet, Stereolithography, P3, and SAF. Its software is GrabCAD Software, Connectivity, Digital Anatomy Creator, and OpenAM Software. It generates revenue through 3D printing systems, related services, and consumables and by providing additive manufacturing solutions.